KROS Keros Therapeutics, Inc. logo

KROS Keros Therapeutics, Inc.

Healthcare
$11.19-0.27%ClosedMarket Cap: $358.1M

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

170

13F Shares

20,134,402

Ownership %

49.6%

New Positions

41

Increased Positions

81

Closed Positions

32

Reduced Positions

70

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
BBCVirtus Biotech Clinical Trials ETF12,6760.41%
ASQCX16,3240.21%
VSTCX117,4520.10%
EESWisdomTree U.S. SmallCap Fund30,8390.05%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF38,4760.05%
PSCPrincipal U.S. Small-Cap Multi-Factor ETF58,1390.04%
IBBiShares Biotechnology ETF214,7890.03%
VTWV21,3130.03%
PRFZInvesco RAFI US 1500 Small-Mid ETF60,1410.03%
VFMO14,8870.03%
IWNiShares Russell 2000 Value ETF246,0350.02%
NAJ246,0350.02%
VEXRX171,1500.02%
VEXPX171,1500.02%
VTWO144,8540.01%
IWMiShares Russell 2000 ETF716,9260.01%
RSSLGlobal X - Russell 2000 ETF13,3110.01%
NJM716,9260.01%
AVSCAvantis U.S. Small Cap Equity ETF27,9740.01%
DFSVDimensional - US Small Cap Value ETF35,5880.01%